Addressing Minimal Residual Disease in Neuroblastoma by Suppressing α1B Adrenergic Receptor Signaling” - Project IG 2025 ID 32638 – CUP E63C25001860007

Position: Post-doctoral research appointment Institute: Uni. Trento
Posted on: 09/06/2026 Deadline: 29/06/2026

Scientific-Disciplinary Group

06/MEDS-02 - Experimental Medicine, Pathophysiology And Clinical Pathology

Description

The postdoctoral researcher will work within an AIRC-funded project focused on high-risk neuroblastoma, with particular attention to MYCN-amplified disease and relapse after standard multimodal treatment. The project aims to investigate the role of alpha-1B adrenergic receptor signaling in neuroblastoma progression and in the response to differentiation therapy with 13-cis-retinoic acid.

Job posting website

https://lavoraconnoi.unitn.it/incarichi-post-doc/dipartimento-cibio-avviso-di-selezione-il-conferimento-di-n-1-incarico-post-doc-decreto-n-581-2026

Number of positions

1

Funding body

Università di Trento

View the original posting on the MUR website: Go to MUR website

Back to jobs